Hans L. Mooij

Amsterdam, NH 1091AC, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

A Drop of Blood to Lead the Way.

A Drop of Blood to Lead the Way.

Journal: Hematology reports
Published: July 16, 2025

Nitrous oxide abuse leading to extreme homocysteine levels and thrombosis in young adults: a case series.

Nitrous oxide abuse leading to extreme homocysteine levels and thrombosis in young adults: a case series.

Journal: Journal of thrombosis and haemostasis : JTH
Published: May 31, 2022

Phase I dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: The HOVON/LLPC Transplant BRaVE study.

Phase I dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: The HOVON/LLPC Transplant BRaVE study.

Journal: Haematologica
Published: November 02, 2018

Ext1 heterozygosity causes a modest effect on postprandial lipid clearance in humans.

Ext1 heterozygosity causes a modest effect on postprandial lipid clearance in humans.

Journal: Journal of lipid research
Published: January 09, 2015

Loss of function in heparan sulfate elongation genes EXT1 and EXT 2 results in improved nitric oxide bioavailability and endothelial function.

Loss of function in heparan sulfate elongation genes EXT1 and EXT 2 results in improved nitric oxide bioavailability and endothelial function.

Journal: Journal of the American Heart Association
Published: December 04, 2014

Carriers of loss-of-function mutations in EXT display impaired pancreatic beta-cell reserve due to smaller pancreas volume.

Carriers of loss-of-function mutations in EXT display impaired pancreatic beta-cell reserve due to smaller pancreas volume.

Journal: PloS one
Published: April 04, 2014

SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus.

SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus.

Journal: Obesity (Silver Spring, Md.)
Published: September 20, 2013

Rapid insulin-mediated increase in microvascular glycocalyx accessibility in skeletal muscle may contribute to insulin-mediated glucose disposal in rats.

Rapid insulin-mediated increase in microvascular glycocalyx accessibility in skeletal muscle may contribute to insulin-mediated glucose disposal in rats.

Journal: PloS one
Published: July 05, 2012

Inhibition of hepatic sulfatase-2 in vivo: a novel strategy to correct diabetic dyslipidemia.

Inhibition of hepatic sulfatase-2 in vivo: a novel strategy to correct diabetic dyslipidemia.

Journal: Hepatology (Baltimore, Md.)
Published: January 12, 2012
Showing 1-9 of 9

Last Updated: 09/26/2026